Ligatech | Deeply Cultivating the Full Chain to Build a New Benchmark for Domestic Sports Medicine

Shanghai Ligatech Bioscience Co., Ltd., founded in 2014, with its headquarters in the Qingpu Park of Shanghai Zhangjiang Hi-Tech Park. Since its founding, we have anchored ourselves on a clear track:sports medicine. We do not stop at providing a single product, but are committed to building an overall solution covering preoperative diagnosis, surgical treatment and postoperative rehabilitation. Our strategic core direction is“digital sports medicine”, and on this basis we have built three major business areas: imaging systems and artificial intelligence, arthroscopic surgery equipment, and implants together with supporting surgical tools and consumables. All of this revolves around one core clinical goal: function first, helping patients functional recovery and achieve rapid recovery.

A clear strategic positioning and the layout of full-process solutions cannot be achieved without a solid technical foundation as support, and the three core technology platforms are the core confidence of Ligatech's product system.

Diagnosis Layer

Treatment Layer

Implant Layer

Auxiliary Layer

Ligatech has gathered a high-quality, highly educated R&D team, in whichmaster'sanddoctoraldegree holders account for more than25%. The team includes top talents from internationally renowned universities such as MIT, as well as doctoral supervisors from domestic universities such as Shanghai Jiao Tong University. The company also has a post-doctoral workstation, providing a continuous source of intellectual support for technological innovation.

Deeply cultivating the sports medicine track without stopping, Ligatech has already anchored the course of its next journey. In the wave of the rapid rise of domestic sports medicine, we usethe "diagnosis - treatment - repair - reconstruction" full-chain layout as the pen to write Ligatech's full-stack sports medicine new chapter in the trillion-level sports health market. We are anchoring on clinical needs, transforming technological innovation into solutions covering the full cycle of patients, and outlining a grand blueprint for domestic sports medicine.